BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20483563)

  • 61. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
    Kim I; Rajani R
    J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Occult phosphaturic mesenchymal tumor detected by Tc-99m sestamibi scan.
    Siegel HJ; Rock MG
    Clin Nucl Med; 2002 Aug; 27(8):608-9. PubMed ID: 12170016
    [No Abstract]   [Full Text] [Related]  

  • 63. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
    Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
    Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.
    Qari H; Hamao-Sakamoto A; Fuselier C; Cheng YS; Kessler H; Wright J
    Head Neck Pathol; 2016 Jun; 10(2):192-200. PubMed ID: 26577211
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Left maxillary sinus tumour-induced hypophosphataemic osteomalacia and combined with thyroid papillary carcinoma: a case report and literature review.
    Li B; Dong Y; Liu D; Yao Q; Guo S; Xin H; Wang H; Liu L; Zhang Y
    Intern Med J; 2020 Jun; 50(6):755-761. PubMed ID: 32537923
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting--a case report and review of the literature.
    Woznowski M; Quack I; Stegbauer J; Büchner N; Rump LC; Schieren G
    Clin Nephrol; 2008 Nov; 70(5):431-8. PubMed ID: 19000546
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tumour-induced Osteomalacia Secondary to Intracranial Tumours - Report of 2 Cases.
    Gunawat PV; Shaikh ST; Deopujari CE
    J Assoc Physicians India; 2019 Apr; 67(4):85-86. PubMed ID: 31299850
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oncogenic osteomalacia in a patient with an ethmoid sinus tumour.
    Kurien R; Manipadam MT; Rupa V
    J Laryngol Otol; 2010 Jul; 124(7):799-803. PubMed ID: 20003602
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phosphaturic mesenchymal tumor of the tibia with oncogenic osteomalacia in a teenager.
    Farmakis SG; Siegel MJ
    Pediatr Radiol; 2015 Aug; 45(9):1423-6. PubMed ID: 25721582
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings.
    Shustik DA; Ng DC; Sittampalam K
    Int J Clin Exp Pathol; 2015; 8(6):7506-17. PubMed ID: 26261662
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
    Alonso G; Varsavsky M
    Endocrinol Nutr; 2016 Apr; 63(4):181-6. PubMed ID: 26718193
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumor-induced osteomalacia.
    Schapira D; Ben Izhak O; Nachtigal A; Burstein A; Shalom RB; Shagrawi I; Best LA
    Semin Arthritis Rheum; 1995 Aug; 25(1):35-46. PubMed ID: 8525389
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.
    Wasserman JK; Purgina B; Lai CK; Gravel D; Mahaffey A; Bell D; Chiosea SI
    Head Neck Pathol; 2016 Sep; 10(3):279-85. PubMed ID: 26759148
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot.
    Liu S; Zhou X; Song A; Huo Z; Wang Y; Xia W; Liu Y
    Medicine (Baltimore); 2019 Jul; 98(27):e16296. PubMed ID: 31277164
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bilateral subtrochanteric fractures in tumour-induced osteomalacia caused by a nasal haemangiopericytoma.
    Burnand H; Samuels A; Hagan I; Sawant N; Mutimer J
    Hip Int; 2012; 22(2):227-9. PubMed ID: 22547377
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].
    Takahashi M; Toru S; Ota K; Izumiyama H; Yokota T; Mizusawa H
    Rinsho Shinkeigaku; 2008 Feb; 48(2):120-4. PubMed ID: 18326305
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical, morphological and immunohistochemical analysis of 13 cases of phosphaturic mesenchymal tumor - A holistic diagnostic approach.
    Chatterjee D; Bardia A; Pal R; Saikia UN; Bhadada SK; Radotra BD
    Ann Diagn Pathol; 2021 Oct; 54():151783. PubMed ID: 34329884
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Whole-body MR imaging in detecting phosphaturic mesenchymal tumor (PMT) in tumor-induced hypophosphatemic osteomalacia.
    Nakanishi K; Sakai M; Tanaka H; Tsuboi H; Hashimoto J; Hashimoto N; Tomiyama N
    Magn Reson Med Sci; 2013 Mar; 12(1):47-52. PubMed ID: 23474956
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [FGF23 tumor induced osteomalacia with localization of neoplasm in the tympanic cavity].
    Ovchinnikov AY; Khon EM; Bakotina AV; Miroshnichenko NA; Gronskaia SA; Belaya ZE
    Vestn Otorinolaringol; 2023; 88(6):91-96. PubMed ID: 38153899
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dual paraneoplastic syndromes: small cell lung carcinoma-related oncogenic osteomalacia, and syndrome of inappropriate antidiuretic hormone secretion: report of a case and review of the literature.
    Tantisattamo E; Ng RC
    Hawaii Med J; 2011 Jul; 70(7):139-43. PubMed ID: 21886301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.